Oral Bacitracin: A Consideration for Suppression of Intestinal Vancomycin-Resistant Enterococci (VRE) and for VRE Bacteremia From an Apparent Gastrointestinal Tract Source.
作者信息
Tran Truc T, Palmer Hannah R, Weimar Marion R, Arias Cesar A, Cook Gregory M, Murray Barbara E
机构信息
Division of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston University of Houston College of Pharmacy.
Department of Pharmacy, Baylor St Luke's Medical Center, Houston, Texas.
出版信息
Clin Infect Dis. 2015 Jun 1;60(11):1726-8. doi: 10.1093/cid/civ130. Epub 2015 Feb 19.
Abstract
摘要
相似文献
1
Oral Bacitracin: A Consideration for Suppression of Intestinal Vancomycin-Resistant Enterococci (VRE) and for VRE Bacteremia From an Apparent Gastrointestinal Tract Source.口服杆菌肽：抑制肠道耐万古霉素肠球菌（VRE）及预防源自明显胃肠道来源的VRE菌血症的一种考量。
Clin Infect Dis. 2015 Jun 1;60(11):1726-8. doi: 10.1093/cid/civ130. Epub 2015 Feb 19.
2
Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia.万古霉素耐药粪肠球菌菌血症的临床特征和治疗结局。
J Microbiol Immunol Infect. 2018 Dec;51(6):705-716. doi: 10.1016/j.jmii.2017.08.025. Epub 2017 Oct 5.
3
Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients.比较标准剂量、中剂量和高剂量达托霉素治疗退伍军人事务部患者耐万古霉素肠球菌菌血症的疗效和安全性。
Clin Infect Dis. 2017 Mar 1;64(5):605-613. doi: 10.1093/cid/ciw815.
4
Therapeutic options for vancomycin-resistant enterococcal bacteremia.耐万古霉素肠球菌菌血症的治疗选择
Expert Rev Anti Infect Ther. 2015 Mar;13(3):363-77. doi: 10.1586/14787210.2015.1001839.
5
E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.粪肠球菌万古霉素敏感型肠球菌菌血症，对万古霉素耐受菌株无反应，经高剂量达托霉素成功治疗。
Heart Lung. 2007 Nov-Dec;36(6):456-61. doi: 10.1016/j.hrtlng.2007.02.012.
6
Association of daptomycin dosing regimen and mortality in patients with VRE bacteraemia: a review.万古霉素耐药肠球菌菌血症患者的达托霉素给药方案与死亡率的相关性：综述。
J Antimicrob Chemother. 2018 Sep 1;73(9):2277-2283. doi: 10.1093/jac/dky072.
7
Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci.口服抗菌药物在根除耐万古霉素肠球菌胃肠道定植方面的失败。
Infect Control Hosp Epidemiol. 2002 Jan;23(1):43-4. doi: 10.1086/501968.
8
[Treatment of vancomycin-resistant enterococcal infections].[耐万古霉素肠球菌感染的治疗]
Ugeskr Laeger. 2018 Apr 16;180(16).
9
Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.在体外药代动力学/药效学模拟心内膜赘生物模型中评估达托霉素联合头孢曲松对耐万古霉素肠球菌的新组合疗效。
J Antimicrob Chemother. 2014 Aug;69(8):2148-54. doi: 10.1093/jac/dku113. Epub 2014 Apr 28.
10
Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?万古霉素耐药肠球菌菌血症与达托霉素：是否需要更高剂量？
J Antimicrob Chemother. 2011 Sep;66(9):2112-8. doi: 10.1093/jac/dkr255. Epub 2011 Jun 22.
引用本文的文献
1
High prevalence and plasmidome diversity of -positive enterococci in a Shenzhen community, China.中国深圳某社区中阳性肠球菌的高流行率及质粒组多样性
Front Microbiol. 2024 Dec 20;15:1505107. doi: 10.3389/fmicb.2024.1505107. eCollection 2024.
2
A classic antibiotic reimagined: Rationally designed bacitracin variants exhibit potent activity against vancomycin-resistant pathogens.经典抗生素的再设计：经过合理设计的杆菌肽变体对耐万古霉素的病原体具有强大的活性。
Proc Natl Acad Sci U S A. 2024 Jul 16;121(29):e2315310121. doi: 10.1073/pnas.2315310121. Epub 2024 Jul 11.
3
Chemically Tuning Resveratrol for the Effective Killing of Gram-Positive Pathogens.化学调控白藜芦醇有效杀灭革兰阳性病原体。
J Nat Prod. 2022 Jun 24;85(6):1459-1473. doi: 10.1021/acs.jnatprod.1c01107. Epub 2022 May 27.
4
Selective digestive decontamination with oral colistin plus gentamicin for persistent bacteraemia caused by non-carbapenemase-producing carbapenem-resistant in a neutropenic patient.在一名中性粒细胞减少患者中，使用口服黏菌素加庆大霉素进行选择性消化道去污治疗由非碳青霉烯酶产生的耐碳青霉烯菌引起的持续性菌血症。
JAC Antimicrob Resist. 2021 Jun 21;3(2):dlab079. doi: 10.1093/jacamr/dlab079. eCollection 2021 Jun.
5
Phenylthiazole Antibacterial Agents Targeting Cell Wall Synthesis Exhibit Potent Activity in Vitro and in Vivo against Vancomycin-Resistant Enterococci.靶向细胞壁合成的苯基噻唑类抗菌剂在体外和体内对耐万古霉素肠球菌均表现出强大活性。
J Med Chem. 2017 Mar 23;60(6):2425-2438. doi: 10.1021/acs.jmedchem.6b01780. Epub 2017 Mar 15.
6
The Two-Component System ChtRS Contributes to Chlorhexidine Tolerance in Enterococcus faecium.双组分系统ChtRS有助于粪肠球菌对洗必泰的耐受性。
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02122-16. Print 2017 May.
7
Multilevel selection of bcrABDR-mediated bacitracin resistance in Enterococcus faecalis from chicken farms.鸡场粪肠球菌中 bcrABDR 介导的杆菌肽耐药性的多层次选择。
Sci Rep. 2016 Oct 12;6:34895. doi: 10.1038/srep34895.
本文引用的文献
1
Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature.去定植万古霉素耐药粪肠球菌的胃肠道定植：病例系列和文献回顾。
BMC Infect Dis. 2014 Sep 23;14:514. doi: 10.1186/1471-2334-14-514.
2
Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.既往已定植的造血干细胞移植患者中耐万古霉素肠球菌血症危险因素的评估。
Transpl Infect Dis. 2013 Oct;15(5):466-73. doi: 10.1111/tid.12120. Epub 2013 Aug 4.
3
Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapy.万古霉素敏感屎肠球菌株及其治疗中出现的万古霉素耐药变异株的全基因组分析。
Antimicrob Agents Chemother. 2013 Jan;57(1):261-8. doi: 10.1128/AAC.01454-12. Epub 2012 Oct 31.
4
Complete genome sequence of Enterococcus faecium strain TX16 and comparative genomic analysis of Enterococcus faecium genomes.屎肠球菌 TX16 株全基因组序列测定及屎肠球菌基因组比较分析。
BMC Microbiol. 2012 Jul 7;12:135. doi: 10.1186/1471-2180-12-135.
5
Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation.肠定植与异基因造血干细胞移植患者发生菌血症的风险。
Clin Infect Dis. 2012 Oct;55(7):905-14. doi: 10.1093/cid/cis580. Epub 2012 Jun 20.
6
Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans.万古霉素耐药肠球菌在肠道微生物群中的主导地位是由小鼠的抗生素治疗所促成的，并且先于人类的血流感染。
J Clin Invest. 2010 Dec;120(12):4332-41. doi: 10.1172/JCI43918. Epub 2010 Nov 22.
7
Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.万古霉素耐药肠球菌（VRE）感染在携带 VRE 的高危发热性中性粒细胞减少症患者中的发生率。
Support Care Cancer. 2010 Feb;19(2):231-7. doi: 10.1007/s00520-009-0808-y. Epub 2010 Jan 13.
8
Persistence of vancomycin-resistant enterococci in New Zealand broilers after discontinuation of avoparcin use.停用阿伏帕星后新西兰肉鸡中耐万古霉素肠球菌的持续性
Appl Environ Microbiol. 2004 Oct;70(10):5764-8. doi: 10.1128/AEM.70.10.5764-5768.2004.
9
Acquired bacitracin resistance in Enterococcus faecalis is mediated by an ABC transporter and a novel regulatory protein, BcrR.粪肠球菌中获得性杆菌肽耐药性由一种ABC转运蛋白和一种新型调节蛋白BcrR介导。
Antimicrob Agents Chemother. 2004 Oct;48(10):3743-8. doi: 10.1128/AAC.48.10.3743-3748.2004.
10
Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium.口服杆菌肽加强力霉素根除耐万古霉素屎肠球菌粪便定植的疗效欠佳。
Clin Infect Dis. 1999 Aug;29(2):361-6. doi: 10.1086/520216.
Zotero 插件